Female sexual dysfunction (FSD) and quality of life (QOL) are both multidimensional and
have a bidirectional relationship across the reproductive life span and beyond …

Background The benefits and risks of testosterone treatment for women with diminished
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …

Introduction Sexual desire, arousal, and orgasm are mediated by complex, yet still not fully
understood, interactions of the somatic and autonomic nervous systems operating at the …

Sexual function worsens with advancing menopause status. The most frequently reported
symptoms include low sexual desire (40–55%), poor lubrication (25–30%) and dyspareunia …

Abstract The International Society for the Study of Women's Sexual Health process of care
(POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was …

Importance In August 2015, the US Food and Drug Administration (FDA) approved
flibanserin as a treatment for hypoactive sexual desire disorder (HSDD) in premenopausal …

Sexual dysfunction in women is a common and often distressing problem that has a
negative impact on quality of life and medication compliance. The problem is often …

Psychiatry and Psychosomatic Medicine are concerned with medical conditions affecting
brain, mind and behaviour in manifold ways. Traditional approaches have focused on a …

Sexual well-being frequently declines following the menopause transition and can be
associated with significant personal and relationship distress. This distress is the hallmark of …

Introduction Since the millennium we have witnessed significant strides in the science and
treatment of female sexual dysfunction (FSD). This forward progress has included (i) the …